ARTICLE | Financial News
NGM raises $50 million in series C
July 19, 2013 12:18 AM UTC
NGM Biopharmaceuticals Inc. (South San Francisco, Calif.) raised $50 million in a series C round from new investor Topspin Fund and existing investors The Column Group; Prospect Venture Partners; Rho ...